Institutional investors control 48.34% of the outstanding shares in HPTX. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2013, these large investors purchased a net $913.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONSONANCE CAPITAL MANAGEMENT LP Bought 651.2 Thousand shares of Hyperion Therapeutics Inc
WELLS CAPITAL MANAGEMENT, INC. Bought 218.2 Thousand shares of Hyperion Therapeutics Inc